Novo Nordisk, the Danish pharmaceutical giant behind the obesity drug Wegovy, said on Wednesday it will cut about 9,000 jobs globally in a major restructuring effort, aiming to save 8 billion Danish crowns ($1.26 billion) annually. The move underscores the growing pressure the company faces from its US rival Eli…
The United States has been the ultimate safe haven for global investors for decades now. Treasuries were unquestioned collateral,…
The UK and China are set to restart high-level trade discussions this week after a seven-year pause, with Britain’s…
Poland shot down drones that entered its airspace during a large-scale Russian attack on western Ukraine on Wednesday, with…
Holiday sales in the United States are set to increase at the slowest pace since the pandemic, according to…
Gold has continued its rally over the last few weeks, with prices hitting a series of record highs. However, the…
Poland invoked NATO’s Article 4 for urgent consultations after 19 Russian drones breached its airspace on the night of…
Gold and crude oil prices extended gains on Wednesday, with copper prices remaining largely unchanged from the previous close. Silver…
Dow futures dipped slightly Wednesday morning as traders waited nervously for producer price inflation data that could influence the…